A Post-marketing Surveillance to Assess Safety and Efficacy of Rosuvatatin/Ezetimibe

NCT03648788 · clinicaltrials.gov ↗

UNKNOWN

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Mixed Dyslipidemia

Interventions

OTHER: NA (Observation study)

Sponsor

IlDong Pharmaceutical Co Ltd